Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion
- 14 June 2012
- journal article
- Published by Elsevier BV in Neuroscience
- Vol. 212, 180-189
- https://doi.org/10.1016/j.neuroscience.2012.03.036
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Modeling Stroke in Mice - Middle Cerebral Artery Occlusion with the Filament ModelJournal of Visualized Experiments, 2011
- Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in ratsJournal of Neurochemistry, 2010
- Matrix Metalloproteinase-9 Regulates Tumor Cell Invasion through Cleavage of Protease Nexin-1Cancer Research, 2010
- Evolution of the Thrombolytic Treatment Window for Acute Ischemic StrokeCurrent Neurology and Neuroscience Reports, 2010
- TTC, Fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusionJournal of Neuroscience Methods, 2009
- Mechanical reperfusion is associated with post-ischemic hemorrhage in rat brainExperimental Neurology, 2009
- Reperfusion activates metalloproteinases that contribute to neurovascular injuryExperimental Neurology, 2008
- Modulation of the proteolytic activity of matrix metalloproteinase-2 (gelatinase A) on fibrinogenBiochemical Journal, 2007
- Experimental Intracerebral Hemorrhage in the MouseStroke, 2003
- Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic StrokeStroke, 2000